Skip to Content
Learn about Adcetris a treatment of Hodgkin Lymphoma

Drug interactions between Sandoglobulin and Stamaril

Results for the following 2 drugs:
Sandoglobulin (immune globulin intravenous)
Stamaril (yellow fever vaccine)

Interactions between your drugs

Moderate

immune globulin intravenous yellow fever vaccine

Applies to: Sandoglobulin (immune globulin intravenous) and Stamaril (yellow fever vaccine)

Immune globulin intravenous may interfere with the immune response to yellow fever vaccine. A person who has been treated with immune globulin intravenous should generally not be vaccinated for several months with a live vaccine. If vaccination was given shortly before or after immune globulin intravenous, a revaccination may be necessary. The immunizing doctor should be informed of recent therapy with immune globulin intravenous so that appropriate measures and/or precautions can be taken. It is important to tell the doctor about all other medications being used, including vitamins and herbs. Do not stop using any medications without first talking to the doctor.

Switch to professional interaction data

Drug and food interactions

No results found in our database - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

Drug Interaction Classification

The classifications below are a guideline only. The relevance of a particular drug interaction to a specific patient is difficult to determine using this tool alone given the large number of variables that may apply.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No information available.

Do not stop taking any medications without consulting your healthcare provider.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide